Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
UK’s Rising Rebate Threatens Branded Generic And Biosimilar Supply
BGMA Warns Of Market Withdrawals And Calls For Government Strategy For Sector
Dec 09 2022
•
By
Dave Wallace
The rising VPAS rate is putting UK supply at risk • Source: Shutterstock
More from Policy & Regulation
More from Generics Bulletin